京新药业：10月10日召开董事会会议

Company Overview - Jingxin Pharmaceutical (SZ 002020) announced the first meeting of its ninth board of directors on October 10, 2025, to review the proposal for the election of committee members [1] - As of the report, Jingxin Pharmaceutical has a market capitalization of 16.9 billion yuan [1] Revenue Composition - For the first half of 2025, the revenue composition of Jingxin Pharmaceutical is as follows: finished drugs account for 58.28%, raw materials account for 22.44%, medical devices account for 17.32%, and other businesses account for 1.95% [1]